166 related articles for article (PubMed ID: 28272512)
1. Genetically-directed Sparse Neuronal Labeling in BAC Transgenic Mice through Mononucleotide Repeat Frameshift.
Lu XH; Yang XW
Sci Rep; 2017 Mar; 7():43915. PubMed ID: 28272512
[TBL] [Abstract][Full Text] [Related]
2. Validating the use of M4-BAC-GFP mice as tissue donors in cell replacement therapies in a rodent model of Huntington's disease.
Döbrössy M; Klein A; Janghra N; Nikkhah G; Dunnett SB
J Neurosci Methods; 2011 Apr; 197(1):6-13. PubMed ID: 21295605
[TBL] [Abstract][Full Text] [Related]
3. Striatal medium-sized spiny neurons: identification by nuclear staining and study of neuronal subpopulations in BAC transgenic mice.
Matamales M; Bertran-Gonzalez J; Salomon L; Degos B; Deniau JM; Valjent E; Hervé D; Girault JA
PLoS One; 2009; 4(3):e4770. PubMed ID: 19274089
[TBL] [Abstract][Full Text] [Related]
4. Drd1a-tdTomato BAC transgenic mice for simultaneous visualization of medium spiny neurons in the direct and indirect pathways of the basal ganglia.
Shuen JA; Chen M; Gloss B; Calakos N
J Neurosci; 2008 Mar; 28(11):2681-5. PubMed ID: 18337395
[No Abstract] [Full Text] [Related]
5. Looking BAC at striatal signaling: cell-specific analysis in new transgenic mice.
Valjent E; Bertran-Gonzalez J; Hervé D; Fisone G; Girault JA
Trends Neurosci; 2009 Oct; 32(10):538-47. PubMed ID: 19765834
[TBL] [Abstract][Full Text] [Related]
6. L-DOPA Oppositely Regulates Synaptic Strength and Spine Morphology in D1 and D2 Striatal Projection Neurons in Dyskinesia.
Suarez LM; Solis O; Aguado C; Lujan R; Moratalla R
Cereb Cortex; 2016 Oct; 26(11):4253-4264. PubMed ID: 27613437
[TBL] [Abstract][Full Text] [Related]
7. Striatal Distribution and Cytoarchitecture of Dopamine Receptor Subtype 1 and 2: Evidence from Double-Labeling Transgenic Mice.
Ren K; Guo B; Dai C; Yao H; Sun T; Liu X; Bai Z; Wang W; Wu S
Front Neural Circuits; 2017; 11():57. PubMed ID: 28860974
[TBL] [Abstract][Full Text] [Related]
8. Novel BAC Mouse Model of Huntington's Disease with 225 CAG Repeats Exhibits an Early Widespread and Stable Degenerative Phenotype.
Wegrzynowicz M; Bichell TJ; Soares BD; Loth MK; McGlothan JS; Mori S; Alikhan FS; Hua K; Coughlin JM; Holt HK; Jetter CS; Pomper MG; Osmand AP; Guilarte TR; Bowman AB
J Huntingtons Dis; 2015; 4(1):17-36. PubMed ID: 26333255
[TBL] [Abstract][Full Text] [Related]
9. A comparison of striatal-dependent behaviors in wild-type and hemizygous Drd1a and Drd2 BAC transgenic mice.
Nelson AB; Hang GB; Grueter BA; Pascoli V; Luscher C; Malenka RC; Kreitzer AC
J Neurosci; 2012 Jul; 32(27):9119-23. PubMed ID: 22764221
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of D1 and D2 dopamine receptor segregation in the developing striatum using BAC transgenic mice.
Thibault D; Loustalot F; Fortin GM; Bourque MJ; Trudeau LÉ
PLoS One; 2013; 8(7):e67219. PubMed ID: 23843993
[TBL] [Abstract][Full Text] [Related]
11. Selective Vulnerability of Striatal D2 versus D1 Dopamine Receptor-Expressing Medium Spiny Neurons in HIV-1 Tat Transgenic Male Mice.
Schier CJ; Marks WD; Paris JJ; Barbour AJ; McLane VD; Maragos WF; McQuiston AR; Knapp PE; Hauser KF
J Neurosci; 2017 Jun; 37(23):5758-5769. PubMed ID: 28473642
[TBL] [Abstract][Full Text] [Related]
12. Brainwide Genetic Sparse Cell Labeling to Illuminate the Morphology of Neurons and Glia with Cre-Dependent MORF Mice.
Veldman MB; Park CS; Eyermann CM; Zhang JY; Zuniga-Sanchez E; Hirano AA; Daigle TL; Foster NN; Zhu M; Langfelder P; Lopez IA; Brecha NC; Zipursky SL; Zeng H; Dong HW; Yang XW
Neuron; 2020 Oct; 108(1):111-127.e6. PubMed ID: 32795398
[TBL] [Abstract][Full Text] [Related]
13. Disturbed Ca2+ signaling and apoptosis of medium spiny neurons in Huntington's disease.
Tang TS; Slow E; Lupu V; Stavrovskaya IG; Sugimori M; Llinás R; Kristal BS; Hayden MR; Bezprozvanny I
Proc Natl Acad Sci U S A; 2005 Feb; 102(7):2602-7. PubMed ID: 15695335
[TBL] [Abstract][Full Text] [Related]
14. Resolving pathobiological mechanisms relating to Huntington disease: gait, balance, and involuntary movements in mice with targeted ablation of striatal D1 dopamine receptor cells.
Kim HA; Jiang L; Madsen H; Parish CL; Massalas J; Smardencas A; O'Leary C; Gantois I; O'Tuathaigh C; Waddington JL; Ehrlich ME; Lawrence AJ; Drago J
Neurobiol Dis; 2014 Feb; 62():323-37. PubMed ID: 24135007
[TBL] [Abstract][Full Text] [Related]
15. Differential electrophysiological changes in striatal output neurons in Huntington's disease.
André VM; Cepeda C; Fisher YE; Huynh M; Bardakjian N; Singh S; Yang XW; Levine MS
J Neurosci; 2011 Jan; 31(4):1170-82. PubMed ID: 21273402
[TBL] [Abstract][Full Text] [Related]
16. Differential D1 and D2 receptor-mediated effects on immediate early gene induction in a transgenic mouse model of Huntington's disease.
Spektor BS; Miller DW; Hollingsworth ZR; Kaneko YA; Solano SM; Johnson JM; Penney JB; Young AB; Luthi-Carter R
Brain Res Mol Brain Res; 2002 Jun; 102(1-2):118-28. PubMed ID: 12191502
[TBL] [Abstract][Full Text] [Related]
17. Full length mutant huntingtin is required for altered Ca2+ signaling and apoptosis of striatal neurons in the YAC mouse model of Huntington's disease.
Zhang H; Li Q; Graham RK; Slow E; Hayden MR; Bezprozvanny I
Neurobiol Dis; 2008 Jul; 31(1):80-8. PubMed ID: 18502655
[TBL] [Abstract][Full Text] [Related]
18. Characterization of dopamine D1 and D2 receptor-expressing neurons in the mouse hippocampus.
Gangarossa G; Longueville S; De Bundel D; Perroy J; Hervé D; Girault JA; Valjent E
Hippocampus; 2012 Dec; 22(12):2199-207. PubMed ID: 22777829
[TBL] [Abstract][Full Text] [Related]
19. Acute binge pattern cocaine administration induces region-specific effects in D1-r- and D2-r-expressing cells in eGFP transgenic mice.
Lawhorn C; Edusei E; Zhou Y; Ho A; Kreek MJ
Neuroscience; 2013 Dec; 253():123-31. PubMed ID: 24001687
[TBL] [Abstract][Full Text] [Related]
20. Striatal D1 medium spiny neuron activation induces dyskinesias in parkinsonian mice.
Perez XA; Zhang D; Bordia T; Quik M
Mov Disord; 2017 Apr; 32(4):538-548. PubMed ID: 28256010
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
